RYSE is one of Europe’s leading health-tech investors with a ground-breaking approach to selecting and rapidly scaling innovative early-stage companies. Our focus is to help founders go further. Investor partnerships - with the largest health-tech accelerator in Europe - and with Novartis, Medtronic, and the NHS, translated great ideas into real-world solutions. Our Dream is to transform 1 billion lives by 2030.